Colorectal Cancer: Preventive Measures, a New Treatment Approach, and Mortality Disparities
The incidence of colorectal cancer – the fourth most common cancer diagnosed in the United States – has been...
The incidence of colorectal cancer – the fourth most common cancer diagnosed in the United States – has been...
Multiple myeloma is a cancer of antibody-producing cells—called plasma cells—that accounts for approximately 1.8 percent of new cancer cases...
A highly complex filtering system, the kidneys process roughly half a cup of blood every minute, isolating waste and...
February is drawing to a close, and it’s time for our monthly staple: the collection of 10 “must read”...
“There’s a clear connection between cancer and the gut microbiome,” began Matthew Redinbo, PhD, at the opening keynote address...
By Carmine S. Leggett, PhD Clinical trials in oncology have changed the face of cancer treatment, allowing cancer researchers...
Circulating tumor DNA (ctDNA) was first detected over 30 years ago, but its potential uses for cancer diagnosis and...
By Trevan Locke, PhD Thanks to a wave of newly approved therapies in the past two decades, survival rates...
Despite considerable progress against cancer, the disease continues to take a huge toll on global health. Each year, approximately...
While there have been great strides in lowering the incidence and mortality rates of cervical cancer in the United...